YD23
YD23 is a PROTAC that induces SMARCA2 degradation, has anticancer activity, and selectively inhibits the growth of SMARCA4 mutant lung cancer cells in vitro.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
738.76
Molecular Formula
C38H39FN8O7
Notes
Research use only, not for human use.
Receptor
PROTACs | Epigenetic Reader Domain
CAS Number
2951015-29-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
22682141 1x10<sup>6</sup> cells/1.0ml
GRIPAP1 CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details